Nuclear Theranostics in Turkey View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-02

AUTHORS

Murat Fani Bozkurt

ABSTRACT

Nuclear theranostics functions as a bridge which connects targeted diagnosis to targeted therapy, just like Turkey functions as a geographical bridge which connects Asia to Europe. This unique geographical site of the country plays an important role with regard to introduction of novel scientific and technologic improvements, which originate from one continent to another, in the era of accelerated information. The first nuclear medicine practice in Turkey started in the beginning of 1950s with the first radioiodine treatment, which actually was a debut for nuclear theranostics in Turkey, years before many other countries in the world. For the time being, along with radioiodine treatment, many other theranostic applications such as I-131 MIBG treatment, Lu-177/Y-90 DOTA peptide treatment, Lu-177 PSMA treatment, Y-90 microsphere treatment, and bone palliative treatment are being performed in many centers countrywide. As science and technology improves, novel theranostic applications are eagerly awaited to be introduced in near future. This paper summarizes the story of nuclear theranostics in Turkey and aims to give an overview on the current status of theranostic applications in Turkey. More... »

PAGES

11-13

References to SciGraph publications

  • 2017-05. Nuclear medicine training and practice in Turkey in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s13139-018-0564-3

    DOI

    http://dx.doi.org/10.1007/s13139-018-0564-3

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1110668572

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30828394


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Hacettepe University", 
              "id": "https://www.grid.ac/institutes/grid.14442.37", 
              "name": [
                "Department of Nuclear Medicine, Hacettepe University Faculty of Medicine, TR-06100, Ankara, Turkey"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bozkurt", 
            "givenName": "Murat Fani", 
            "id": "sg:person.01174505237.24", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174505237.24"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s00259-017-3620-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1083395746", 
              "https://doi.org/10.1007/s00259-017-3620-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-017-3620-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1083395746", 
              "https://doi.org/10.1007/s00259-017-3620-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.4274/mirt.30502", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1100616815"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2019-02", 
        "datePublishedReg": "2019-02-01", 
        "description": "Nuclear theranostics functions as a bridge which connects targeted diagnosis to targeted therapy, just like Turkey functions as a geographical bridge which connects Asia to Europe. This unique geographical site of the country plays an important role with regard to introduction of novel scientific and technologic improvements, which originate from one continent to another, in the era of accelerated information. The first nuclear medicine practice in Turkey started in the beginning of 1950s with the first radioiodine treatment, which actually was a debut for nuclear theranostics in Turkey, years before many other countries in the world. For the time being, along with radioiodine treatment, many other theranostic applications such as I-131 MIBG treatment, Lu-177/Y-90 DOTA peptide treatment, Lu-177 PSMA treatment, Y-90 microsphere treatment, and bone palliative treatment are being performed in many centers countrywide. As science and technology improves, novel theranostic applications are eagerly awaited to be introduced in near future. This paper summarizes the story of nuclear theranostics in Turkey and aims to give an overview on the current status of theranostic applications in Turkey.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1007/s13139-018-0564-3", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1016285", 
            "issn": [
              "1869-3474", 
              "1869-3482"
            ], 
            "name": "Nuclear Medicine and Molecular Imaging", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "53"
          }
        ], 
        "name": "Nuclear Theranostics in Turkey", 
        "pagination": "11-13", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "2ef58eea458146aa9fbde98eb40f6b1536707ad7f903c2d84cbe2f1f90199dc6"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30828394"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "101530478"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s13139-018-0564-3"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1110668572"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s13139-018-0564-3", 
          "https://app.dimensions.ai/details/publication/pub.1110668572"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T11:04", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000352_0000000352/records_60366_00000003.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://link.springer.com/10.1007%2Fs13139-018-0564-3"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0564-3'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0564-3'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0564-3'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0564-3'


     

    This table displays all metadata directly associated to this object as RDF triples.

    76 TRIPLES      21 PREDICATES      31 URIs      21 LITERALS      9 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s13139-018-0564-3 schema:about anzsrc-for:11
    2 anzsrc-for:1103
    3 schema:author Ndfba6400acf444f489a610902619eaf6
    4 schema:citation sg:pub.10.1007/s00259-017-3620-9
    5 https://doi.org/10.4274/mirt.30502
    6 schema:datePublished 2019-02
    7 schema:datePublishedReg 2019-02-01
    8 schema:description Nuclear theranostics functions as a bridge which connects targeted diagnosis to targeted therapy, just like Turkey functions as a geographical bridge which connects Asia to Europe. This unique geographical site of the country plays an important role with regard to introduction of novel scientific and technologic improvements, which originate from one continent to another, in the era of accelerated information. The first nuclear medicine practice in Turkey started in the beginning of 1950s with the first radioiodine treatment, which actually was a debut for nuclear theranostics in Turkey, years before many other countries in the world. For the time being, along with radioiodine treatment, many other theranostic applications such as I-131 MIBG treatment, Lu-177/Y-90 DOTA peptide treatment, Lu-177 PSMA treatment, Y-90 microsphere treatment, and bone palliative treatment are being performed in many centers countrywide. As science and technology improves, novel theranostic applications are eagerly awaited to be introduced in near future. This paper summarizes the story of nuclear theranostics in Turkey and aims to give an overview on the current status of theranostic applications in Turkey.
    9 schema:genre research_article
    10 schema:inLanguage en
    11 schema:isAccessibleForFree false
    12 schema:isPartOf N2b8a64dfabf34b87ab1ec277e574a4f1
    13 N5f689c5377b741e7827aff500b87dd9b
    14 sg:journal.1016285
    15 schema:name Nuclear Theranostics in Turkey
    16 schema:pagination 11-13
    17 schema:productId N0e852fab6a4d48c99b73db925287d942
    18 N2402b21cab5240d498f4ea74f42b4d3b
    19 N7e34525e08564cf7b04b052271ff8c68
    20 N9e83cabab9fb4ab4bd4335044b056cb0
    21 Nf9984f4b593c461d91d83d900e720323
    22 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110668572
    23 https://doi.org/10.1007/s13139-018-0564-3
    24 schema:sdDatePublished 2019-04-11T11:04
    25 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    26 schema:sdPublisher N41c27ae03b16435da2782a7a56b3d3ae
    27 schema:url https://link.springer.com/10.1007%2Fs13139-018-0564-3
    28 sgo:license sg:explorer/license/
    29 sgo:sdDataset articles
    30 rdf:type schema:ScholarlyArticle
    31 N0e852fab6a4d48c99b73db925287d942 schema:name doi
    32 schema:value 10.1007/s13139-018-0564-3
    33 rdf:type schema:PropertyValue
    34 N2402b21cab5240d498f4ea74f42b4d3b schema:name pubmed_id
    35 schema:value 30828394
    36 rdf:type schema:PropertyValue
    37 N2b8a64dfabf34b87ab1ec277e574a4f1 schema:volumeNumber 53
    38 rdf:type schema:PublicationVolume
    39 N41c27ae03b16435da2782a7a56b3d3ae schema:name Springer Nature - SN SciGraph project
    40 rdf:type schema:Organization
    41 N5f689c5377b741e7827aff500b87dd9b schema:issueNumber 1
    42 rdf:type schema:PublicationIssue
    43 N7e34525e08564cf7b04b052271ff8c68 schema:name readcube_id
    44 schema:value 2ef58eea458146aa9fbde98eb40f6b1536707ad7f903c2d84cbe2f1f90199dc6
    45 rdf:type schema:PropertyValue
    46 N9e83cabab9fb4ab4bd4335044b056cb0 schema:name dimensions_id
    47 schema:value pub.1110668572
    48 rdf:type schema:PropertyValue
    49 Ndfba6400acf444f489a610902619eaf6 rdf:first sg:person.01174505237.24
    50 rdf:rest rdf:nil
    51 Nf9984f4b593c461d91d83d900e720323 schema:name nlm_unique_id
    52 schema:value 101530478
    53 rdf:type schema:PropertyValue
    54 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    55 schema:name Medical and Health Sciences
    56 rdf:type schema:DefinedTerm
    57 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    58 schema:name Clinical Sciences
    59 rdf:type schema:DefinedTerm
    60 sg:journal.1016285 schema:issn 1869-3474
    61 1869-3482
    62 schema:name Nuclear Medicine and Molecular Imaging
    63 rdf:type schema:Periodical
    64 sg:person.01174505237.24 schema:affiliation https://www.grid.ac/institutes/grid.14442.37
    65 schema:familyName Bozkurt
    66 schema:givenName Murat Fani
    67 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174505237.24
    68 rdf:type schema:Person
    69 sg:pub.10.1007/s00259-017-3620-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083395746
    70 https://doi.org/10.1007/s00259-017-3620-9
    71 rdf:type schema:CreativeWork
    72 https://doi.org/10.4274/mirt.30502 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100616815
    73 rdf:type schema:CreativeWork
    74 https://www.grid.ac/institutes/grid.14442.37 schema:alternateName Hacettepe University
    75 schema:name Department of Nuclear Medicine, Hacettepe University Faculty of Medicine, TR-06100, Ankara, Turkey
    76 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...